Stay updated with breaking news from Jane Wasman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces changes to its Board of Directors following the Company’s recent 2023 Annual Meeting of Stockholders. Current Director Jane Wasman, JD, has been ap...
Athersys, Inc. , a regenerative medicine company developing MultiStem® for critical care indications, announces changes to its Board of Directors following the Company’s recent 2023 Annual...
A look at the most prominent Northeast Ohio business stories of the past week.
The Cleveland-based regenerative medicine company, which is undertaking cost-cutting and restructuring efforts, cut the size of the board of directors in half ahead of the annual meeting of shareholders. That meeting will take place on Thursday, July 28.
Athersys Announces Board of Directors Slate for 2022 Annual Meeting of Stockholders and Director Departures - read this article along with other careers information, tips and advice on BioSpace